# Lifevantage (LFVN) Stock Price, News & Catalysts
Canonical URL: https://biopharmsignal.com/company/LFVN
## Company Profile
- Ticker: LFVN
- Exchange: NASDAQ
- Sector: Biopharma
- Location: United States
## Stock Data
- Close: 6.03 USD
- Market cap: 108748385.63999999 USD
- Last updated: 2026-10-05
## Business Overview
### Direct-Selling Wellness Company
LifeVantage develops and markets nutritional supplements and personal-care products through a network of independent consultants.
### Nutrigenomics Positioning
The company's products are marketed around activation of cellular pathways associated with antioxidant response, metabolism and healthy aging rather than conventional nutrient replacement alone.
### Product Portfolio
Key offerings include the Protandim line, the MindBody GLP-1 System and products added through LoveBiome. Sales depend on consultant recruitment, customer retention and product launches across international markets.
## Why The Stock Is Moving

As of Oct 5, 2026, LFVN closed down 0.66% at $6.03. No new same-company headline was identified in the current news window.

## Future Catalysts

- LifeVantage’s catalysts are product sales, distributor activity, and margin discipline in consumer wellness. The company improves when its recurring consumer base stays healthy.

## Recent News
- 2026-09-18 12:00 EST — [LifeVantage to Participate in the WTR Virtual Insights Conference on Wednesday, September 23, 2026](https://biopharmsignal.com/news/LFVN/lifevantage-to-participate-in-the-wtr-virtual-insights-conference-on-wednesday-s-8818d3c0) — Source: Lifevantage
- 2026-08-27 20:05 EST — [LifeVantage Announces Financial Results for the Fourth Fiscal Quarter and Full Fiscal Year 2026](https://biopharmsignal.com/news/LFVN/lifevantage-announces-financial-results-for-the-fourth-fiscal-quarter-and-full-f-e5b39982) — Source: Lifevantage
- 2026-08-21 12:00 EST — [LifeVantage Declares Quarterly Dividend](https://biopharmsignal.com/news/LFVN/lifevantage-declares-quarterly-dividend-51b7e471) — Source: Lifevantage
- 2026-08-13 20:30 EST — [LifeVantage to Announce Fourth Quarter and Full Fiscal Year 2026 Results on August 27, 2026](https://biopharmsignal.com/news/LFVN/lifevantage-to-announce-fourth-quarter-and-full-fiscal-year-2026-results-on-augu-990d304c) — Source: Lifevantage
- 2026-08-11 21:00 EST — [LifeVantage Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)](https://biopharmsignal.com/news/LFVN/lifevantage-announces-inducement-grants-under-nasdaq-listing-rule-5635-c-4-68d4bbe5) — Source: Lifevantage